Blackston Financial Advisory Group »

C4 Therapeutics shares owned by Blackston Financial Advisory Group

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Blackston Financial Advisory Group from 13F filings

Historical chart of Blackston Financial Advisory Group investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Blackston Financial Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Blackston Financial Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $19k 10k 1.91

More positions owned by Blackston Financial Advisory Group

Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Sp 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard World Mega Cap Index (MGC)
Vanguard World Consum Stp Etf (VDC)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Whitehall Fds High Div Yld (VYM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard World Inf Tech Etf (VGT)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)

View all positions for Blackston Financial Advisory Group

Top funds holding C4 Therapeutics

Point72 Asset Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
OrbiMed Advisors
Vanguard Group
Daniel D. Thurber
Soleus Capital Management
Millennium Management
Silverarc Capital Management
BlackRock
Susquehanna International
Renaissance Technologies
Goldman Sachs Group
Geode Capital Management
Jane Street

View all funds holding C4 Therapeutics